Entering text into the input field will update the search result below

FDA staff finds J&J COVID vaccine effective ahead of review

Feb. 24, 2021 8:44 AM ETJohnson & Johnson (JNJ) StockJNJBy: Dulan Lokuwithana, SA News Editor21 Comments
  • The FDA has released the briefing document for the COVID-19 vaccine candidate from Johnson & Johnson (NYSE:JNJ) ahead of its review scheduled for later this week.
  • The company shares are trading ~1.5% higher in the pre-market.
  • Based on preliminary late-stage trial data, the single-dose shot

Recommended For You

About JNJ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
JNJ--
Johnson & Johnson